Expert opinion on NSCLC small specimen biomarker testing - Part 2: Analysis, reporting, and quality assessment.

The diagnostic work-up for non-small cell lung cancer (NSCLC) requires biomarker testing to guide therapy choices. This article is the second of a two-part series. In Part 1, we summarised evidence-based recommendations for obtaining and processing small specimen samples (i.e. pre-analytical steps)...

Descripción completa

Detalles Bibliográficos

Publicado en:	Virchows Archiv: European Journal of Pathology Vol. 481; no. 3; pp. 351 - 367
Autores principales:	Penault-Llorca, Frédérique, Kerr, Keith M., Garrido, Pilar, Thunnissen, Erik, Dequeker, Elisabeth, Normanno, Nicola, Patton, Simon J., Fairley, Jenni, Kapp, Joshua, de Ridder, Daniëlle, Ryška, Aleš, Moch, Holger
Formato:	research Journal Article
Publicado:	Springer Nature Sep2022
Acceso en línea:	Ver este registro en EBSCOhost